Confirma, iCAD to market combined mammo and breast MRI CAD technologies

TriMed Staff | | Health Imaging | Breast MRI
Computer-aided detection (CAD) firms Confirma Inc. and iCAD Inc. have signed an agreement to market each other's respective CAD technologies.

Confirma specializes in CAD for breast MRI, while iCAD offers CAD for x-ray mammography. The goal, the companies say, is to provide a better, more streamlined breast MRI and mammography CAD product through an enhanced version of iCAD's Second Look CAD system.

Confirma will provide CADstream to iCAD for integration with the Second Look 500 CAD system for mammography. The new products will be known as the Second Look 500M and will be available in July. Results of the CADstream analysis are available on the Second Look review station, allowing radiologists concurrent access to mammography and MR CAD results while reviewing original patient films.

TriMed Staff

Related Content

New low-field scanner detects cancer spread better than traditional breast MRI
MRI technique makes breast cancer 'glow' on imaging
Deep learning reconstruction cuts breast MRI scan times in half
AI effectively flags mammograms of women who would benefit from supplemental MRI
AI model spots up to 30% of breast cancers missed on MRI
Breast cancer only visible via MRI is often less aggressive

Around the web

Cardiovascular Business
GE HealthCare launches new cardiac CT scanner with advanced AI capabilities

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Cardiovascular Business
Bracco updates HeartSee coronary flow capacity software with new diagnostic features

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

Cardiovascular Business
Key trends in diagnostic heart testing: CT on the rise as some traditional techniques fall out of favor

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.